Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

Stock Information for Helius Medical Technologies Inc. Class A common shares

Loading

Please wait while we load your information from QuoteMedia.